Blunting the synergistic effect of viral infections and allergies--IgE testing for at-risk asthma patients.
Results from s-IgE testing can help PCPs implement guideline-based asthma management and reduce the morbidity associated with the synergistic effects of allergen sensitization/exposure and seasonal viral exposure.
ImmunoDiagnostics Division, Thermo Fisher Scientific.
Robert
R
Reinhardt
D000293:Adolescent; D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000150:complications / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000276:immunology*; D007073:Immunoglobulin E / Q000097:blood* / Q000276:immunology*; D011237:Predictive Value of Tests; D012307:Risk Factors; D014777:Virus Diseases / Q000150:complications / Q000276:immunology*
D000485:Allergens; D007073:Immunoglobulin E